Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)
Original languageUndefined/Unknown
JournalJournal of acquired immune deficiency syndromes (1999)
DOIs
Publication statusPublished - Apr 2015

Cite this